Rep. Lisa C. McClain Sells Off Shares of Penumbra, Inc. (NYSE:PEN)

Key Points

• Representative Lisa C. McClain sold shares of Penumbra, Inc. (NYSE:PEN) valued between $1,001 and $15,000 on July 10th, in addition to other recent trades in various companies.
• Penumbra’s stock opened at $252.99 with a market cap of $9.87 billion and reported earnings per share (EPS) of $0.86 for the last quarter, exceeding analyst expectations.
• Analysts maintain a moderate buy rating on Penumbra with a consensus target price of $300.47, indicating potential for future growth despite recent insider stock sell-offs.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Penumbra, Inc. NYSE: PEN. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Penumbra stock on July 10th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Penumbra Stock Performance

Shares of PEN opened at $252.99 on Friday. The firm has a market cap of $9.87 billion, a PE ratio of 67.28, a PEG ratio of 2.28 and a beta of 0.40. The stock's fifty day moving average price is $246.04 and its two-hundred day moving average price is $265.62. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.75 and a quick ratio of 4.04. Penumbra, Inc. has a 1 year low of $184.80 and a 1 year high of $310.00.

Penumbra (NYSE:PEN - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.05. The firm had revenue of $339.46 million for the quarter, compared to analyst estimates of $327.37 million. Penumbra had a return on equity of 11.55% and a net margin of 11.54%. The business's revenue was up 13.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.64 earnings per share. On average, equities research analysts forecast that Penumbra, Inc. will post 3.67 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. BTIG Research restated a "buy" rating on shares of Penumbra in a research note on Thursday, April 24th. Morgan Stanley boosted their target price on Penumbra from $260.00 to $266.00 and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Stifel Nicolaus set a $318.00 price objective on Penumbra and gave the company a "buy" rating in a research note on Thursday, April 24th. Canaccord Genuity Group set a $350.00 price objective on Penumbra and gave the company a "buy" rating in a research note on Wednesday, July 30th. Finally, Royal Bank Of Canada decreased their price objective on Penumbra from $330.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $300.47.

Hedge Funds Weigh In On Penumbra

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC boosted its holdings in shares of Penumbra by 7.3% in the 2nd quarter. GAMMA Investing LLC now owns 761 shares of the company's stock worth $195,000 after purchasing an additional 52 shares in the last quarter. Baker Avenue Asset Management LP boosted its holdings in shares of Penumbra by 1.6% in the 4th quarter. Baker Avenue Asset Management LP now owns 3,330 shares of the company's stock worth $791,000 after purchasing an additional 53 shares in the last quarter. Fifth Third Bancorp boosted its holdings in shares of Penumbra by 16.4% in the 1st quarter. Fifth Third Bancorp now owns 404 shares of the company's stock worth $108,000 after purchasing an additional 57 shares in the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Penumbra by 70.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 160 shares of the company's stock worth $41,000 after purchasing an additional 66 shares in the last quarter. Finally, Quadrant Capital Group LLC boosted its holdings in shares of Penumbra by 2.9% in the 2nd quarter. Quadrant Capital Group LLC now owns 2,872 shares of the company's stock worth $737,000 after purchasing an additional 82 shares in the last quarter. 88.88% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Penumbra

In other news, EVP Johanna Roberts sold 600 shares of the company's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $258.17, for a total value of $154,902.00. Following the completion of the transaction, the executive vice president directly owned 64,714 shares in the company, valued at approximately $16,707,213.38. This represents a 0.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Maggie Yuen sold 2,000 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $250.00, for a total value of $500,000.00. Following the completion of the transaction, the chief financial officer owned 12,943 shares of the company's stock, valued at $3,235,750. The trade was a 13.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 112,487 shares of company stock valued at $27,969,587 over the last quarter. 4.20% of the stock is owned by company insiders.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.